FindMyKOL

Amresh Raina, MD

Basic profile

Allegheny Health Network

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionPittsburgh, PA · NortheastSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Amresh Raina is a Cardiology physician affiliated with Allegheny Health Network. OpenAlex indexes 174 publications with 3,346 citations (h-index 27).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
174publications

Publications indexed by OpenAlex. Counts exclude supporting files.

3,346citations

Citations across these publications.

27h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Merck & Co.
    Program year20255 paymentsResearch
    $132,049
  • United Therapeutics
    Program year202515 paymentsResearch
    $20,892
  • Janssen
    Program year202518 paymentsResearch
    $15,913
All 40 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.9%
    Loop diuretic11.2%
    Bumetanide54%Furosemide34%Torsemide12%
    Part D<11 patients
    Beta blocker11.2%
    Carvedilol50%Metoprolol Succinate43%Metoprolol Tartrate8%
    Part D<11 patients

    + 17 more classes in this area

  • Blood & clotting

    10%
    Factor Xa inhibitor4%
    Eliquis100%
    Part D≥26 patients
    Prostacyclin Receptor Agonist2.3%
    Uptravi100%
    Part D<11 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    8.9%
    Proton pump inhibitor3.5%
    Pantoprazole Sodium57%Omeprazole43%
    Part D<11 patients
    Potassium supplement2.4%
    Potassium Chloride80%Klor-Con M2020%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)78.9% facility · 21.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”